Additional Treatment Benefits For Patients: Our Exclusive License Agreement

Additional Treatment Benefits For Patients: Our Exclusive License Agreement

The work of Dr. Joanne Kurtzberg and her colleagues at Duke University aims to bring novel cord blood and cord tissue-based cellular therapies to the clinic. Per the license agreement, additional patients will be provided access to cord blood and cord tissue treatments under Investigational New Drug Applications (INDs) currently held by Duke at a forthcoming Cryo-Cell stem cell infusion clinic, expected to open in early 2022.


Read More


UC-MSCs Are Explored For Treatment of Spine Conditions

UC-MSCs Are Explored For Treatment of Spine Conditions

Bone marrow MSCs, adipose tissue MSCs, umbilical cord MSCs and mononuclear cells have long been used in transplantations for a wide array of treatments. Umbilical cord blood and cord tissue-derived mesenchymal stem cells (UC-MSCs) are undergoing several clinical trial phases to test the safety and efficacy for use in infusions for patients with low back pain (LBP), intervertebral disc degeneration (IVD), and spinal cord injury (SCI).


Read More


Cord Tissue Processing Key Role in Regenerative Medicine

Cord Tissue Processing Key Role in Regenerative Medicine

Stem cells derived from cord tissue are increasingly being utilized in regenerative medicine for a wide range of conditions. The latest research points to the critical importance of storing the cord tissue pieces rather than enzymatic digestion before cryopreservation to maximize the likelihood of use.


Read More


Stem Cell Scientists Awarded Nobel Prize

Stem Cell Scientists Awarded Nobel Prize

The 2012 Nobel Prize Award in Physiology or Medicine emphasizes the expectation that scientists and physicians have for the potential of using engineered adult stem cells to heal humans.
 

Read More


Cryo-Cell International

Cryo-Cell HQ
 
The World’s First Cord Blood Bank

Founded in 1989, Cryo-Cell is the world's first family cord blood bank.  More than 500,000 parents from 87 countries have entrusted Cryo-Cell (and our affiliates) with their baby’s cord blood collections.  Since inception, 100% of our clients’ collections have been successfully viable upon thaw, a statement that no other cord blood bank has made. Cryo-Cell's services include umbilical cord blood and cord tissue banking. Cryo-Cell's industry leading, state-of-the-art laboratory and storage facility are situated adjacent to its corporate headquarters. This proximity allows our executives to directly oversee the daily operation of the most secured, efficient, and technically advanced facility.